Onglyza approved in Europe

pharmafile | October 6, 2009 | News story | Sales and Marketing EU, Onglyza, diabetes 

Related Content

CHMP recommends Novo Nordisk’s Awiqli for diabetes treatment

Novo Nordisk has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for …

Roche shares data on novel solution for continuous glucose monitoring

Roche has shared the latest data on its novel solution for continuous glucose monitoring (CGM), …

Novo Nordisk shares positive results from COMBINE 3 phase 3a trial

Novo Nordisk has shared topline results from the COMBINE 3 phase 3a trial of once-weeklly …

Latest content